Government Decree No. 419 / 2024 Coll.
Government Regulation amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended
Valid
Regulation
Effective from 01.01.2025
419
GOVERNMENT REGULATION
of 11 December 2024
amending Government Regulation No 463 / 2013 Coll., on substance lists, as amended
The Government orders pursuant to § 44c paragraphs 1 and 2 of Act No. 167 / 1998 Coll., on addictive substances and on the amendment of certain other laws, as amended by Act No. 273 / 2013 Coll. and Act No. 366 / 2021 Coll.:
Government Regulation No. 463 / 2013 Coll., on substance lists, as amended by Government Regulation No. 243 / 2015 Coll., Government Regulation No. 46 / 2017 Coll., Government Regulation No. 30 / 2018 Coll., Government Regulation No. 242 / 2018 Coll., Government Regulation No. 184 / 2021 Coll., Government Regulation No. 159 / 2022 Coll., Government Regulation No. 228 / 2023 Coll., Government Regulation No. 52 / 2024 Coll. and Government Regulation No. 176 / 2024 Coll., are amended as follows:
1. In the table in Annex No 1, under the line in the column headed "International non-proprietary name (INN) in Czech ', the word" Thebacon' is inserted, the word "methyl 4- (N- (2-methoxyacetyl) aniline) -1- (2-thiophen-2-ylethyl) piperidin-4-carboxylate 'is inserted in the column entitled" Chemical name according to IUPAC', the word "methyl 4- (N- (2- methoxyacetyl) aniline 'is inserted in the column entitled" 2- thiophene-2- ylethyl) piperidin the column entitled "Note' and the words" A-3080, Thianil '.
2. Annex 3 shall read as follows:
"Annex No 3
List No 3 Narcotics
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Acetylbenzylfentanyl | benzylacetylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid | NSC 73750 |
| Acetylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid | ||
| Acryloylfentanyl | Acrylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid | |
| AH-7921 | 3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid | ||
| AP-237 | bucinnazin; 1-N-butyryl-4cinnamylpiperazine; | 1-[4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| AP-238 | 1-[2,6-dimethyl-4-(3-fenylprop-2-enyl)piperazin-1-yl]propan-1-on | ||
| Benzodioxolfentanyl | BZD-F; benzodioxole-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2H-1,3-benzodioxol-5-karboxamid | |
| Benzoylbenzylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid | ||
| Benzoylfentanyl | fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid | |
| Benzylfentanyl | Benzyl-F; R 4129 | N-fenyl-N-[1-(fenylmethyl)piperidin-4-yl]propanamid | |
| Benzylfuranylfentanyl | Benzyl FuF | N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid | |
| Bromadolin | U 4793e; U 47931E | 4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid | |
| Brorfin | Brorphine | 3-{1-[1-(4-bromfenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-on | |
| Butonitazen | 2-[(4-butoxyfenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazol-1-ethanamin | ||
| 4-Chlorisobutyrfentanyl | 4-Cl-iBF | N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| Cyklopentylfentanyl | cyclopentyl-F; CP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid | |
| Cyklopropylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid | ||
| Desmethylmoramid | R530 | 4-(4-morfolinyl)-2,2-difenyl-1-(1-pyrrolidinyl)-1-butanon | |
| Desomorfin | 4,5α-epoxy-17-methylmorfinan-3-ol | ||
| Despropionyl-2-fluor fentanyl | N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Despropionyl-4-fluor fentanyl | N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Dipyanon | 4,4-difenyl-6-(pyrrolidin-1-yl)heptan-3-on | ||
| Etazen | etodesnitazene | 2-[2-[(4-ethoxyfenyl)methyl]benzimidazol-1-yl]-N,N-diethylethanamin | |
| Ethylenoxynitazen | 2-{2-[(2,3-dihydro-1-benzofuran-5-yl)methyl]-5-nitro-1H-benzimidazol-1-yl}-N,Ndiethylethan-1-amin | ||
| Etometazen | 5-methyl etodesnitazen; 5-methyl desnitroetonitazen | 2-[(4-ethoxyfenyl)methyl]-N,N-diethyl-5-methyl-1H-benzimidazol-1-ethanamin | |
| Etonitazepipne | N-piperidinyletonitazen | 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazol | |
| Etonitazepin | 2-[(4-ethoxyfenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzoimidazol | ||
| Etorfin | (5R,6R,7R,14R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorfinan-3-ol | ||
| Fentanyl butanamid analog | butyrfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
| 3-Fenylpropanoylfentanyl | β'-fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-3-fenylpropanamid | hydrocinnamoylfentanyl |
| Flunitazen | N,N-diethyl-2-{2-[(4-fluorfenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}ethanamin | ||
| 2’-Fluor-2-fluor-3-methylfentanyl | N-(1-(2-fluorfenethyl)-3-methylpiperidin-4-yl)-N-(2-fluorfenyl)propionamid | ||
| 4-Fluor-butyrfentanyl | 4F-BF | N-(4-fluorfenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid | |
| 4-Fluor-cyklopropylbenzylfentanyl | para-fluorcyklopropylbenzylfentanyl | N-(4-fluorfenyl)-N-(1-benzylpiperidin-4-yl)-cyklopropankarboxamid | |
| 2-Fluorfentanyl | Ortofluorfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 2-FF, o-FF |
| 3-Fluorfentanyl | Metafluorfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 3-FF, m-FF |
| 4-Fluorfuranylfentanyl | para-fluorfuranylfentanyl; 4Ffuranylfentanyl | N-(4-fluorfenyl)-N-(1-fenethylpiperidin-4-yl)furan-2-karboxamid | |
| 4-Fluorisobutyrfentanyl | 4F-iBF | N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 3-Fluormethoxyacetylfentanyl | ortho-fluormethoxyacetylfentanyl | N-(3-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 2F-viminol | 2-[di(butan-2-yl)amino]-1-[1-(2-fluorbenzyl)-1H-pyrrol-2-yl]ethan-1-ol | ||
| Furanyl UF-17 | N-[2-(dimethylamino)cyklohexyl]-N-fenyl-furan-2-karboxamid | ||
| Furanylfentanyl | FU-F; 2-furanoylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid | |
| (iso)Butyryl-F-fentanyl N-benzyl analog | N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid | ||
| Heroin | (5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát | ||
| 4-hydroxybutyrfentanyl | 4-HO-BF; p-hydroxybutyryl fentanyl | N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid | |
| Isobutyrfentanyl | 2-methyl-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]propanamid | ||
| Isopropyl-U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid | ||
| Isotonitazen | N,N-diethyl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1H-benzimidazol-1-ethan amin | ||
| Karbonyl-bromadol | (4-bromfenyl)-(1-(dimethylamino)-4-hydroxy-4-fenethylcyklohexyl)methanon | ||
| Ketobemidon | 1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on | ||
| Konopí | S výjimkou konopí pro léčebné použití uvedené v seznamu č. 1 | ||
| Krotonylfentanyl | (2E)-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2-butenamid | ||
| Methoxyacetylfentanyl | Methoxy-AcF | 2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 4-Methoxybutyr fentanyl | 4-MeO-BF | N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]butanamid | |
| 2-Methylacetylfentanyl | o-methylacetylfentanyl | N-(2-methylfenyl)-N-[1-(2-fenylethyl)-piperidin-4-yl]-acetamid | |
| 2-Methyl-AP-237 | 2-methyl-bucinnazin | 1-[2-methyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| 3,4-Methylendioxy-U-47700 | 3,4-MDO-U-47700; 3,4-MDU-47700; MDU-47; MDU-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methylbenzo[d][1,3]dioxol-5-karboxamid | |
| α-Methylfentanyl butanamid analog | BF; B-F | 2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid | |
| 3-Methylkrotonylfentanyl | β'-methylkrotonylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-piperidin-4-yl]-3-methylbut-2-enamid | |
| Metodesnitazen | N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]benzimidazol-1-yl]ethanamin | ||
| Metonitazen | N,N-diethyl-2-[2-[(4-methoxyfenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamin | ||
| Metonitazepin | 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazol | ||
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)piperazin | ||
| N-desethyl etonitazen | 2-[2-[(4-ethoxyfenyl)methyl]-5-nitro-benzimidazol-1-yl]-N-ethyl-ethanamin | ||
| N-desethyl isotonitazen | N-ethyl-2-[2-[(4-isopropoxyfenyl)methyl]-5-nitro-benzimidazol-1-yl]ethanamin | ||
| N-methyl U-47931E | N-methylbromadolin | 4-brom-N-(2-(dimethylamino)cyklohexyl)-N-methylbenzamid | |
| Nortilidin | ethyl 2-methylamino-1-fenylcyklohex-3-en-1-karboxylát | ||
| O-AMKD; acetoxymethylketobemidon | 3-(4-acetyl-1-methylpiperidin-4-yl)fenyl acetát | ||
| OCfentanyl | A-3217 | N-(2-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| Piperidylthiambuten | piperidinohton, PBN, 127C49 | 1-(4,4-di(thiofen-2-yl)but-3-en-2-yl)piperidin | |
| Protonitazen | N,N-diethyl-5-nitro-2-[(4-propoxyfenyl)methyl]-1-H-benzimidazol-1-ethanamin | ||
| Protonitazepin | 5-nitro-2-[(4-propoxyphenyl)methyl]-1-(2-pyrrolidin-1-ylethyl)benzimidazole | ||
| Pryskyřice z konopí | |||
| Tetrahydrofuranfentanyl | THF-F | N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid | |
| Tetramethylcyklopropanfentanyl | TMCP-fentanyl; TMCP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyklopropan-1karboxamid | |
| Thiofenfentanyl | 2-thiofuranyl fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid | |
| 4-(Trifluormethyl) U-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methyl-4-(trifluormethyl)benzamid | ||
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-48800 | 2-(2,4-dichlorfenyl)-N-(2-(dimethylamino)cyklohexyl)-N-methylacetamid | ||
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-50488 | 3,4-dichlor-N-methyl-N-[2-(1-pyrrolidinyl)cyklohexyl] benzenacetamid | ||
| U-51754 | 2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid | ||
| Valerylfentanyl | TCE, VF | N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; fentanyl pentanamid analog |
Including salts of narcotic substances listed in this group in all cases where such salts may exist. '
3. In the table in Annex No 6, under the line in the column entitled "International non-proprietary name (INN) in the Czech language ', the word" Cyclobarbital' is inserted, the line in the column entitled "International non-proprietary name (INN) in the Czech language 'contains the word" Gamabutyrolactone', the word "additional international non-proprietary name or other generic name 'is inserted, the word" GBL' is entered in the column entitled "Chemical name according to IUPAC 'is entered in the column" oxolan-2-on' and the word "Note 'is entered in the column entitled" gammatobutyrolactone'.
Technical Regulation
This Regulation has been notified in accordance with Directive (EU) 2015 / 1535 of the European Parliament and of the Council of 9 September 2015 laying down a procedure for the provision of information in the field of technical and information society services.
Efficacy
This Regulation shall enter into force on 1 January 2025, with the exception of Article I (3), which shall take effect on 1 April 2025.
Prime Minister:
Prof. PhDr. Fiala, Ph.D., LL.M., v. r.
Deputy Prime Minister and Minister for Health:
Prof. MUDr. Válek, CSc., MBA, EBIR, v. r.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Regulation No. 419 / 2024 Coll., amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended |
|---|---|
| Regulation Type | Regulation |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 18.12.2024 |
|---|---|
| Effective from | 01.01.2025 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0